Posts

Showing posts with the label chemotherapy

Alveolar Rhabdomyosarcoma Treatment; Depends On the Size, Location, and Stage of the Tumor

Image
  Alveolar Rhabdomyosarcoma Treatment often includes surgery, chemotherapy, and radiation therapy (radiotherapy). Moreover, the treatment of rhabdomyosarcoma has greatly improved the care of patients over the past few decades. Around 80% of patients with rhabdomyosarcoma (low-risk) can now be cured. Alveolar rhabdomyosarcoma (ARMS) refers to one subtype of the rhabdomyosarcoma family of soft tissue tumors. While, rhabdomyosarcoma is a rare type of cancer that forms in soft tissue; may occur at any age, often affects children. Alveolar Rhabdomyosarcoma Treatment , such as chemotherapy, is given by injection into a vein. In North America, drugs such as cyclophosphamide (Neosar, Clafen, Cytoxan,), dactinomycin (Cosmegen, Lyovac Cosmegen), and vincristine (Vincasar, Oncovin) are commonly used to treat rhabdomyosarcoma. This combination of drugs is often called Vincristine, actinomycin D, and cyclophosphamide (VAC), an abbreviation for a chemotherapy combination used to treat rhabdomyosarc

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Monochloroacetic Acid (MCAA) Market Is Estimated To Witness High Growth Owing To Increasing Demand for Surfactants and Herbicides